BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25667327)

  • 1. Permissivity of primary hepatocytes and hepatoma cell lines to support hepatitis C virus infection.
    Wilson GK; Farquhar MJ; Meredith L; Dhawan A; Mitry R; Balfe P; McKeating JA
    J Gen Virol; 2015 Jun; 96(Pt 6):1369-1373. PubMed ID: 25667327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus infection of neuroepithelioma cell lines.
    Fletcher NF; Yang JP; Farquhar MJ; Hu K; Davis C; He Q; Dowd K; Ray SC; Krieger SE; Neyts J; Baumert TF; Balfe P; McKeating JA; Wong-Staal F
    Gastroenterology; 2010 Oct; 139(4):1365-74. PubMed ID: 20538002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants Involved in Hepatitis C Virus and GB Virus B Primate Host Restriction.
    Marnata C; Saulnier A; Mompelat D; Krey T; Cohen L; Boukadida C; Warter L; Fresquet J; Vasiliauskaite I; Escriou N; Cosset FL; Rey FA; Lanford RE; Karayiannis P; Rose NJ; Lavillette D; Martin A
    J Virol; 2015 Dec; 89(23):12131-44. PubMed ID: 26401036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatoma cell density promotes claudin-1 and scavenger receptor BI expression and hepatitis C virus internalization.
    Schwarz AK; Grove J; Hu K; Mee CJ; Balfe P; McKeating JA
    J Virol; 2009 Dec; 83(23):12407-14. PubMed ID: 19776133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specialization of Hepatitis C Virus Envelope Glycoproteins for B Lymphocytes in Chronically Infected Patients.
    Douam F; Bobay LM; Maurin G; Fresquet J; Calland N; Maisse C; Durand T; Cosset FL; Féray C; Lavillette D
    J Virol; 2016 Jan; 90(2):992-1008. PubMed ID: 26537674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permissiveness of human hepatocellular carcinoma cell lines for hepatitis C virus entry and replication.
    Coto-Llerena M; Koutsoudakis G; Boix L; López-Oliva JM; Caro-Pérez N; Fernández-Carrillo C; González P; Gastaminza P; Bruix J; Forns X; Pérez-Del-Pulgar S
    Virus Res; 2017 Aug; 240():35-46. PubMed ID: 28751105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus is restricted at both entry and replication in mouse hepatocytes.
    Park IW; Ndjomou J; Fan Y; Henao-Mejia J; He JJ
    Biochem Biophys Res Commun; 2009 Sep; 387(3):489-93. PubMed ID: 19619513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the Host Range of Hepatitis C Virus through Viral Adaptation.
    von Schaewen M; Dorner M; Hueging K; Foquet L; Gerges S; Hrebikova G; Heller B; Bitzegeio J; Doerrbecker J; Horwitz JA; Gerold G; Suerbaum S; Rice CM; Meuleman P; Pietschmann T; Ploss A
    mBio; 2016 Nov; 7(6):. PubMed ID: 27834208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus infection of cholangiocarcinoma cell lines.
    Fletcher NF; Humphreys E; Jennings E; Osburn W; Lissauer S; Wilson GK; van IJzendoorn SCD; Baumert TF; Balfe P; Afford S; McKeating JA
    J Gen Virol; 2015 Jun; 96(Pt 6):1380-1388. PubMed ID: 25701818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of claudin-6 and claudin-9 as entry factors for hepatitis C virus infection of human hepatocytes by using monoclonal antibodies.
    Fofana I; Zona L; Thumann C; Heydmann L; Durand SC; Lupberger J; Blum HE; Pessaux P; Gondeau C; Reynolds GM; McKeating JA; Grunert F; Thompson J; Zeisel MB; Baumert TF
    J Virol; 2013 Sep; 87(18):10405-10. PubMed ID: 23864633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatoma polarization limits CD81 and hepatitis C virus dynamics.
    Harris HJ; Clerte C; Farquhar MJ; Goodall M; Hu K; Rassam P; Dosset P; Wilson GK; Balfe P; Ijzendoorn SC; Milhiet PE; McKeating JA
    Cell Microbiol; 2013 Mar; 15(3):430-45. PubMed ID: 23126643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of hepatitis C virus entry on viral tropism.
    Ding Q; von Schaewen M; Ploss A
    Cell Host Microbe; 2014 Nov; 16(5):562-8. PubMed ID: 25525789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of mouse hepatocyte lines permissive for hepatitis C virus (HCV).
    Aly HH; Oshiumi H; Shime H; Matsumoto M; Wakita T; Shimotohno K; Seya T
    PLoS One; 2011; 6(6):e21284. PubMed ID: 21731692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permissivity of primary human hepatocytes and different hepatoma cell lines to cell culture adapted hepatitis C virus.
    Helle F; Brochot E; Fournier C; Descamps V; Izquierdo L; Hoffmann TW; Morel V; Herpe YE; Bengrine A; Belouzard S; Wychowski C; Dubuisson J; Francois C; Regimbeau JM; Castelain S; Duverlie G
    PLoS One; 2013; 8(8):e70809. PubMed ID: 23940646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary hepatocytes as targets for hepatitis C virus replication.
    Farquhar MJ; McKeating JA
    J Viral Hepat; 2008 Dec; 15(12):849-54. PubMed ID: 19087224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of human factors CD81, claudin-1, scavenger receptor, and occludin in mouse hepatocytes does not confer susceptibility to HCV entry.
    Hikosaka K; Noritake H; Kimura W; Sultana N; Sharkar MT; Tagawa Y; Uezato T; Kobayashi Y; Wakita T; Miura N
    Biomed Res; 2011 Apr; 32(2):143-50. PubMed ID: 21551950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection of Hepatocytes With HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Up-regulating SMAD6 and SMAD7.
    Zhang F; Sodroski C; Cha H; Li Q; Liang TJ
    Gastroenterology; 2017 Jan; 152(1):257-270.e7. PubMed ID: 27693511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell death-inducing DFFA-like effector b is required for hepatitis C virus entry into hepatocytes.
    Wu X; Lee EM; Hammack C; Robotham JM; Basu M; Lang J; Brinton MA; Tang H
    J Virol; 2014 Aug; 88(15):8433-44. PubMed ID: 24829338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic cells derived from induced pluripotent stem cells of pigtail macaques support hepatitis C virus infection.
    Sourisseau M; Goldman O; He W; Gori JL; Kiem HP; Gouon-Evans V; Evans MJ
    Gastroenterology; 2013 Nov; 145(5):966-969.e7. PubMed ID: 23891978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C.
    Schaefer EA; Meixiong J; Mark C; Deik A; Motola DL; Fusco D; Yang A; Brisac C; Salloum S; Lin W; Clish CB; Peng LF; Chung RT
    World J Gastroenterol; 2016 Dec; 22(45):9954-9965. PubMed ID: 28018102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.